Recent Finacing
Recent Raise
Chimera Bioengineering develops the GOLD Platform to engineer CAR‑T cells that selectively activate in solid tumors and deliver payloads to counteract the suppressive tumor microenvironment.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Chimera Bioengineering.
